leadf
logo-loader
RNS
viewIofina PLC

Iofina PLC - Debt Update

RNS Number : 1438X
Iofina PLC
26 August 2020
 

 

26 August 2020

 

Iofina Plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Debt Update

 

Iofina, a specialist in the exploration and production of iodine and manufacturers of specialty chemical products, today provides a brief update to the market regarding debt refinancing.

 

The Company is pleased to report continued positive progress regarding debt refinancing with a new USA lender (the "Lender"). The necessary internal approvals have now been obtained by the Lender and therefore the transaction is now in the final legal documentation phase.  The specifics of the transaction will be detailed to the market once documentation is complete and finalised.  General terms include a term loan as well as a revolving line of credit which will allow Iofina to fully pay current debt holders.  The Company and its new lender are both pushing to complete this transaction as soon as practically possible.

 

Commenting, President and CEO of Iofina Dr. Tom Becker, stated: "We are pleased that we are now in the final documentation phase of debt refinancing and we look forward to updating the market as to its conclusion in due course."

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Matthew Radley (corporate finance)

Tim Redfern (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Joe Burgess

Yellow Jersey PR Limited

Tel: +44 (0)20 3004 9512

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in the production of Iodine and the manufacturing of specialty chemical products. As the second largest producer of iodine in North America, it comprises three USA entities; Iofina Resources, Iofina Chemical and IofinaEX.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates five producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine based products for over 35 years.

 

IofinaEX

Iofina's newest subsidiary, IofinaEX, is fully licensed to process hemp in the state of Kentucky and is exploring the isolation of specialty chemical products from hemp, a rapidly expanding market.

 

www.iofina.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVVWRRKUWUAR

Quick facts: Iofina PLC

Price: 14

Market: LSE
Market Cap: £26.86 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

'Things are adding up for Iofina' with increased year-on-year production

Tom Becker, chief executive of Iofina plc (LON:IOF), tells Proactive Investors 2017 was a year of 'substantial' progress for the company. Gross profit increased by US$2.2m from US$2.7mln to US$4.9mln while underlying earnings (EBITDA) improved by US$2.7m from a deficit of US$1.3mln to a...

on 30/4/18